Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEXTENZA Versus Topical Steroid or Antihistamine Therapy for Treatment of Allergic Conjunctivitis

NCT04708821 is registered in ClinicalTrials.gov with Clinical Research Center of Florida as lead sponsor.

NCT NCT04708821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEXTENZA Versus Topical Steroid or Antihistamine Therapy for Treatment of Allergic Conjunctivitis
Lead sponsor
Clinical Research Center of Florida
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2021
Completion date
September 2, 2021
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral conjunctivitis (disorder)